XETRA - Delayed Quote EUR
BB Biotech AG (BBZA.DE)
33.30
+0.65
+(1.99%)
At close: June 10 at 5:35:44 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 2.02 | 2.4 |
| Low Estimate | 0 | 0 | 2.02 | 2.4 |
| High Estimate | 0 | 0 | 2.02 | 2.4 |
| Year Ago EPS | -- | -- | 1.47 | 2.02 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 575.4M | 306.1M |
| Low Estimate | -- | -- | 575.4M | 306.1M |
| High Estimate | -- | -- | 575.4M | 306.1M |
| Year Ago Sales | -- | -- | 111.55M | 575.4M |
| Sales Growth (year/est) | -- | -- | 415.83% | -46.80% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 2.02 | 2.4 |
| 7 Days Ago | 0 | 0 | 2 | 2.41 |
| 30 Days Ago | 0 | 0 | 2 | 2.42 |
| 60 Days Ago | 0 | 0 | 2 | 2.42 |
| 90 Days Ago | 0 | 0 | 2 | 2.42 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BBZA.DE | -- | -- | 37.93% | 18.80% |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Related Tickers
AYJ.DE Valneva SE
2.7000
+0.07%
88Q.DE 4basebio PLC
12.80
-0.78%
NVV1.DE Novavax, Inc.
7.85
-0.53%
7V0.DE Darwin AG
31.80
-0.63%
BIO.DE Biotest Aktiengesellschaft
42.20
-0.94%
NP5.DE Newron Pharmaceuticals S.p.A.
8.19
-0.97%
BIO3.DE Biotest Aktiengesellschaft
28.40
-3.40%
VX1.DE Vertex Pharmaceuticals Incorporated
391.85
-0.20%
9VC.DE Atai Life Sciences N.V.
1.9950
-2.68%
UR9.F Clinuvel Pharmaceuticals Limited
5.85
+1.65%